Skyports and SkyDrive Advance Urban Air Mobility with Tokyo eVTOL Demonstrations
Tokyo recently hosted a series of demonstration flights showcasing the potential of electric vertical takeoff and landing (eVTOL) aircraft for urban air mobility (AAM). The five-day event, held from February 24-28, 2026, featured remotely piloted flights of SkyDrive’s SD-05 eVTOL aircraft and highlighted the integration of Skyports’ Vertiport Automation System (VAS).
Demonstrating eVTOL Integration in Tokyo
The demonstrations were part of a program initiated by the Tokyo Metropolitan Government to explore how eVTOLs, often referred to as “flying cars,” can be integrated into Japan’s transportation network. SkyDrive collaborated with Mitsubishi Estate Co., Kanematsu Corporation, and Skyports Infrastructure on the project.
Skyports’ Vertiport Automation System in Action
Skyports’ VAS served as the central technical component for both ground and flight operations. The system integrated with SkyDrive’s SD-05 aircraft to provide real-time monitoring of airspace, weather data, and situational awareness. VAS also managed landing and takeoff slots and oversaw ground equipment digitally. Flight data was integrated into the airspace monitoring system to support automated control and remote piloting of the aircraft.
Passenger Experience and Terminal Technology
A temporary passenger terminal, also integrated with VAS, was established to simulate the passenger experience. Features included facial recognition check-in, security screening, flight information displays, and boarding guidance, all designed to minimize passenger dwell time. The Skyports operations room provided a comprehensive overview of all aspects of the demonstration, including ground and flight operations, airspace monitoring, and passenger status.
Industry Perspectives
Yun Yuan Tay, Head of APAC at Skyports Infrastructure, stated that the demonstration “cements Japan’s ambitions when it comes to integrating AAM within the fabric of its urban environments.” Tay emphasized the importance of safety, efficiency, and passenger experience for the successful implementation of AAM, and highlighted Skyports’ role in providing the necessary link between ground and air operations.
Public Participation and Future Development
SkyDrive also invited members of the public to participate in testing the passenger flow through the terminal facility, including check-in, security, and boarding procedures. This initiative aimed to gather feedback and refine the passenger experience for future eVTOL services. The demonstrations align with the Tokyo Metropolitan Government’s roadmap for introducing eVTOL infrastructure.
Related reading
- WhatsApp Chats Shed Light on Murdered Karachi Trader Mir Raza Ali’s Death
- Basilicata Extends Housing Grants for Bucaletto Families Until 2027
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)
- Best European Autumn Destinations: Sun, Foliage, and Cheap Flights (archyde.com)